Waters Corporation · NYSE (us_market)
Healthcare · Diagnostics & Research · United States
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. The company operates through two segments, Waters and TA. The company designs, manufactures, sells, and services liquid chromatography, as well as mass spectrometry (MS) technology systems and supports products, including chromatography columns, and other consumable products. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer goods, and healthcare products, as well as for life science research; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology, which is used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.
| Event Period | Drawdown | Buy Point (Bottom) | Sell Point (Peak) | ticker.setupCols.buyScore | ticker.setupCols.sellScore | Max Return | Algo Return |
|---|---|---|---|---|---|---|---|
DROP2026-01-06$400.54 RISE2026-04-29$292.13 PEAK2026-05-29$383.57 143d | -27.1% 113d | Missed | Missed | — | — | +31.3% 30d | Missed |
DROP2025-11-25$412.54 RISE2026-03-12$283.32 PEAK2026-05-29$383.57 185d | -31.3% 107d | Missed | Missed | — | — | +35.4% 78d | Missed |
DROP2025-05-20$362.10 RISE2025-09-25$287.79 PEAK2025-11-25$412.54 189d | -20.5% 128d | Missed | Missed | — | — | +43.3% 61d | Missed |
DROP2025-03-27$370.59 RISE2025-08-06$277.72 PEAK2025-10-24$359.50 211d | -25.1% 132d | Missed | Missed | — | — | +29.4% 79d | Missed |
DROP2025-01-30$417.28 RISE2025-04-08$307.71 PEAK2025-05-12$366.67 102d | -26.3% 68d | Missed | Missed | — | — | +19.2% 34d | Missed |
DROP2024-05-15$361.79 RISE2024-07-01$282.70 PEAK2024-08-01$352.53 78d | -21.9% 47d | Missed | Missed | — | — | +24.7% 31d | Missed |
DROP2024-03-07$361.00 RISE2024-04-18$294.23 PEAK2024-05-15$361.79 69d | -18.5% 42d | Missed | Missed | — | — | +23.0% 27d | Missed |
DROP2023-08-08$296.73 RISE2023-10-30$236.70 PEAK2023-12-27$333.04 141d | -20.2% 83d | Missed | Missed | — | — | +40.7% 58d | Missed |
DROP2023-02-02$344.24 RISE2023-06-09$249.28 PEAK2023-08-08$296.73 187d | -27.6% 127d | Missed | Missed | — | — | +19.0% 60d | Missed |
DROP2022-08-01$365.55 RISE2022-09-30$269.53 PEAK2022-12-02$347.37 123d | -26.3% 60d | Missed | Missed | — | — | +28.9% 63d | Missed |
DROP2021-12-31$372.60 RISE2022-04-26$288.88 PEAK2022-07-11$349.94 192d | -22.5% 116d | Missed | Missed | — | — | +21.1% 76d | Missed |
DROP2020-07-27$227.45 RISE2020-09-24$189.64 PEAK2020-12-17$250.74 143d | -16.6% 59d | Missed | Missed | — | — | +32.2% 84d | Missed |
DROP2020-02-20$217.34 RISE2020-06-26$174.76 PEAK2020-07-27$227.45 158d | -19.6% 127d | 2020-03-23 $162.36 | 2020-07-15 $220.80 | 75Deep Value | 41Watch | +30.1% 31d | +36.0% Held 114d |
DROP2020-01-22$244.09 RISE2020-05-01$178.08 PEAK2020-07-27$227.45 187d | -27.0% 100d | 2020-03-23 $162.36 | 2020-07-15 $220.80 | 75Deep Value | 41Watch | +27.7% 87d | +36.0% Duplicate trade Held 114d |
DROP2020-01-22$244.09 RISE2020-03-23$162.36 PEAK2020-06-05$208.93 135d | -33.5% 61d | 2020-03-23 $162.36 | 2020-06-05 $208.93 | 75Deep Value | 47Watch | +28.7% 74d | +28.7% Held 74d |
Waters Corporation has underperformed the broader market over the past year, but analysts are cautiously optimistic about the stock’s prospects.
Waters Corporation has underperformed the broader market over the past year, but analysts are cautiously optimistic about the stock’s prospects.
Waters Corporation (WAT) remains a 'Hold'âthe mergerâs long-term value is still uncertain despite initial optimism and strong revenue growth.
The latest earnings report from Waters Corporation ( NYSE:WAT ) disappointed investors. Our analysis suggests that...
The latest earnings report from Waters Corporation ( NYSE:WAT ) disappointed investors. Our analysis suggests that...
Waters Corporation (NYSE:WAT) announced that Udit Batra, Ph.D., Waters President and Chief Executive Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Wednesday, June 3rd, 2026, at 10:30 AM Eastern Time.
After the stock’s decline this year, do Wall Street analysts see a recovery in Becton, Dickinson and Company?
Waters Corporation’s first quarter saw a strong market response, as the company delivered results ahead of Wall Street’s revenue and earnings expectations despite headline sales declining year over year. Management pointed to robust organic growth in its legacy divisions and better-than-expected early performance from recently acquired Biosciences and Diagnostic Solutions businesses. CEO Udit Batra credited the swift execution of a 180-day integration plan and operational improvements for drivin
Waters Corporation’s first quarter saw a strong market response, as the company delivered results ahead of Wall Street’s revenue and earnings expectations despite headline sales declining year over year. Management pointed to robust organic growth in its legacy divisions and better-than-expected early performance from recently acquired Biosciences and Diagnostic Solutions businesses. CEO Udit Batra credited the swift execution of a 180-day integration plan and operational improvements for drivin
Examine the evolution of Waters' (WAT) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
Examine the evolution of Waters' (WAT) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
Wells Fargo analyst Brandon Couillard maintains Waters (NYSE:WAT) with a Equal-Weight and raises the price target from $355 to $370.
Waters Corporation (NYSE:WAT) has completed a merger with BD’s Biosciences and Diagnostic Solutions businesses. The transaction is described as transformative for Waters, more than doubling its revenue base. Management is targeting operational synergies and pointing to strong early execution and demand in pharmaceutical markets. The combined company is placing greater focus on biologics, along with government and academic customers. Waters is best known for its analytical instruments and...
Waters Corporation (NYSE:WAT) has completed a merger with BD’s Biosciences and Diagnostic Solutions businesses. The transaction is described as transformative for Waters, more than doubling its revenue base. Management is targeting operational synergies and pointing to strong early execution and demand in pharmaceutical markets. The combined company is placing greater focus on biologics, along with government and academic customers. Waters is best known for its analytical instruments and...
Is WAT a good stock to buy? We came across a bullish thesis on Waters Corporation on The Wealth Dynasty Report’s Substack. In this article, we will summarize the bulls’ thesis on WAT. Waters Corporation’s share was trading at $301.88 as of May 4th. WAT’s trailing and forward P/E were 28.54 and 21.37 respectively according to Yahoo […]
Is WAT a good stock to buy? We came across a bullish thesis on Waters Corporation on The Wealth Dynasty Report’s Substack. In this article, we will summarize the bulls’ thesis on WAT. Waters Corporation’s share was trading at $301.88 as of May 4th. WAT’s trailing and forward P/E were 28.54 and 21.37 respectively according to Yahoo […]
This is part of a series of articles discussing recent orders of interest issued in patent cases by the United States District Court for the District of Massachusetts.In two related opinions, Judge...
Artisan Partners, an investment management company, released its first-quarter 2026 investor letter for the “Artisan Mid Cap Fund”. A copy of the letter is available to download here. In Q1 2026, the Artisan Mid Cap Fund reported negative absolute returns but slightly outperformed the Russell Midcap® Growth Index. The market favored lower volatility and income-oriented equities, […]
Artisan Partners, an investment management company, released its first-quarter 2026 investor letter for the “Artisan Mid Cap Fund”. A copy of the letter is available to download here. In Q1 2026, the Artisan Mid Cap Fund reported negative absolute returns but slightly outperformed the Russell Midcap® Growth Index. The market favored lower volatility and income-oriented equities, […]
PHO's portfolio is light on water exposure, with top holdings like Waters, Roper, and Ecolab being only modestly linked to the theme. See why PHO ETF is a Hold.
| 30d | 90d | YTD | 1y | |
|---|---|---|---|---|
| WAT | +24.89% | +24.85% | +0.98% | +9.83% |
| XLV | +2.97% | -5.72% | -3.44% | +12.69% |
| Alpha (stock − sector) | +21.92% | +30.56% | +4.43% | -2.86% |
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| StateStreet | passive | 4.36M | $1.30B | 0.04% | Added+62.6% | 2026-03-31 |
| Viking | long/short | 1.26M | $374.17M | 1.05% | New | 2026-03-31 |
| DEShaw | quant | 1.03M | $305.32M | 0.18% | Added+191.3% | 2026-03-31 |
| Wellington | fundamental | 811.3K | $241.61M | 0.05% | Added+197.5% | 2026-03-31 |
| FidelityFMR | fundamental | 502.8K | $149.74M | 0.01% | Added+214.0% | 2026-03-31 |
| Citadel | multi-strat | 354.4K | $105.53M | 0.14% | Added+462.9% | 2026-03-31 |
| TwoSigma | quant | 13.2K | $3.92M | 0.00% | Added+60.1% | 2026-03-31 |
| TRowePrice | fundamental | 1.12M | $334.74K | 0.04% | Added+67.5% | 2026-03-31 |
| Filed | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-14 | Chaubal Amol | SVP & Chief Financial Officer | F Tax withholding | 239 | $352.21 | −$84.2K |
| 2026-04-07 | Bennett Jianqing | SVP Waters Adv. Diagnostics | F Tax withholding | 302 | $304.09 | −$91.8K |
| 2026-04-02 | Knight Heather | Director | A Grant / award | 68 | — | +$0 |
| 2026-04-02 | Jiang Wei | Director | A Grant / award | 64 | — | +$0 |
| 2026-03-18 | Jiang Wei | Director | P Open-market purchase | 500 | $289.46 | +$144.7K |
| 2026-03-10 | FEARON RICHARD H | Director | P Open-market purchase | 1,000 | $306.34 | +$306.3K |
| 2026-03-03 | Bennett Jianqing | SVP Waters Adv. Diagnostics | F Tax withholding | 410 | $307.23 | −$126.0K |
| 2026-03-03 | Chaubal Amol | SVP & Chief Financial Officer | F Tax withholding | 709 | $307.23 | −$217.8K |
| 2026-03-03 | Batra Udit | President and CEO | F Tax withholding | 3,417 | $307.23 | −$1.05M |
| 2026-02-27 | Ornskov Flemming | Director | A Grant / award(deriv) | 57 | — | +$0 |
| 2026-02-27 | Ornskov Flemming | Director | A Grant / award | 336 | — | +$0 |
| 2026-02-27 | BADDOUR LINDA | Director | A Grant / award(deriv) | 57 | — | +$0 |
| 2026-02-27 | BADDOUR LINDA | Director | A Grant / award | 23 | — | +$0 |
| 2026-02-27 | Brennan Daniel J. | Director | A Grant / award(deriv) | 57 | — | +$0 |
| 2026-02-27 | Brennan Daniel J. | Director | A Grant / award | 23 | — | +$0 |
| 2026-02-27 | FEARON RICHARD H | Director | A Grant / award(deriv) | 57 | — | +$0 |
| 2026-02-27 | FEARON RICHARD H | Director | A Grant / award | 23 | — | +$0 |
| 2026-02-27 | Fraser Claire | Director | A Grant / award(deriv) | 877 | — | +$0 |
| 2026-02-27 | Fraser Claire | Director | A Grant / award | 358 | — | +$0 |
| 2026-02-27 | Huang Pearl S | Director | A Grant / award(deriv) | 57 | — | +$0 |
| 2026-02-27 | Huang Pearl S | Director | A Grant / award | 23 | — | +$0 |
| 2026-02-27 | Jiang Wei | Director | A Grant / award(deriv) | 57 | — | +$0 |
| 2026-02-27 | Jiang Wei | Director | A Grant / award | 23 | — | +$0 |
| 2026-02-27 | Knight Heather | Director | A Grant / award(deriv) | 57 | — | +$0 |
| 2026-02-27 | Knight Heather | Director | A Grant / award | 23 | — | +$0 |
| Report Date | EPS Estimate | EPS Actual | Surprise |
|---|---|---|---|
| 2026-07-29upcoming | 3.03 | — | — |
| 2026-05-05 | 2.31 | 2.70 | +16.99% |
| 2026-02-09 | 4.51 | 4.53 | +0.46% |
| 2025-11-04 | 2.99 | 2.50 | -16.32% |
| 2025-08-04 | 2.94 | 2.95 | +0.26% |
| 2025-05-06 | 2.22 | 2.25 | +1.20% |
| 2025-02-12 | 4.03 | 4.10 | +1.68% |
| 2024-11-01 | 2.68 | 2.93 | +9.38% |
| 2024-07-31 | 2.56 | 2.63 | +2.60% |
| 2024-05-07 | 2.09 | 2.21 | +5.54% |
| 2024-02-06 | 3.55 | 3.62 | +1.88% |
| 2023-11-07 | 2.55 | 2.84 | +11.29% |
| 2023-08-02 | 2.59 | 2.80 | +8.06% |
| 2023-05-09 | 2.62 | 2.49 | -5.11% |
| 2023-02-15 | 3.74 | 3.84 | +2.57% |
| 2022-11-01 | 2.58 | 2.64 | +2.38% |